Anticancer lubrication by LeBrasseur, Nicole
 
940 The Journal of Cell Biology 
 
|
 
 
 
Volume 156, Number 6, 2002
 
Research Roundup Research Roundup
 
 Mice lacking Muc2 had an 
increased ratio of proliferating 
to apoptotic epithelial cells, 
resulting in altered maturation 
and increased migration of 
epithelial cells in the intestine. 
They were also more likely to 
develop intestinal, colon, and 
rectal tumors. The mice are 
the first good model for 
studying rectal tumors, which are common in humans.
Mice lacking Muc2 develop 
colon tumors.
V
e
l
c
i
c
h
/
A
A
A
S
 
Anticancer lubrication
 
new mouse model for the study of cancer reveals that 
mucus lubrication in the intestine is vital for preventing 
tumor formation.
Unregulated expression of Muc2, the most abundant mucin 
in the gastrointestinal lining, is often found in human tumors. 
Furthermore, the goblet cells that synthesize and secrete mucins 
are often depleted in intestinal mucosal structures that 
progress to tumors. These findings led Anna Velcich (Albert 
Einstein Cancer Center/Montefiore Medical Center, Bronx, 
NY) and colleagues to examine the effects of Muc2 during 
the early steps of tumorigenesis.
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The exact pathway from lack of mucin to cancer is not known. 
c-Myc overexpression was present, but the nuclear accumulation 
of 
 
 
 
-catenin and the overt inflammatory response present in 
other mouse models were not found in the Muc2 mutants. 
Velcich speculates that Muc2 may shield cells from noxious 
molecules in the lumen content, such as bile acids, that may 
trigger cell proliferation.
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Coming undone at the seams
 
ells come unglued and transition to a more motile 
phenotype with the help of an E3 ligase, according to 
new results from Walter Birchmeier and colleagues (Max-
Delbrück-Center for Molecular Medicine, Berlin, Germany).
Birchmeier’s study focused on cadherins, adhesion molecules 
that act as anchors via a catenin link to the actin cytoskeleton. 
During embryogenesis and carcinoma progression, disruption 
of cadherin-mediated adhesion between epithelial cells helps 
them make the transition to a more mobile, mesenchymal 
phenotype. This transition involves endocytosis of cadherin 
and catenin molecules following phosphorylation by tyrosine 
kinases such as Src or c-Met.
In the new study, Birchmeier identified a cadherin-binding 
protein, Hakai, that promotes endocytosis of the cadherin 
complex, leading to disruption of cell adhesion. Hakai binds 
to E-cadherin, the prototypical member of the cadherin family, 
in a phosphorylation-dependent manner. It also competes 
with other adhesion molecules, such as p120ctn, for E-cadherin 
binding.
Birchmeier says that “Hakai smelled of degradation,” as it 
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A trip to the ER
 
ephosphorylation of activated receptor tyrosine kinases 
(RTKs) involves a trip to the surface of the ER, according to 
new results from Benjamin Neel (Beth Israel-Deaconess Medical 
Center, Boston, MA), Philippe Bastiaens (EMBL, Heidelberg, 
Germany), and colleagues.
The new results demonstrate that the protein 
tyrosine phosphatase PTP1B dephosphorylates 
RTKs at distinct locations on the cytoplasmic 
face of the ER. Although it was shown that the 
ER-localized PTP1B interacts with and can 
dephosphorylate several growth factor receptors, 
Neel says it was generally thought that 
dephosphorylation at this location was simply 
reversing gratuitous autophosphorylation 
during RTK synthesis in the ER.
The groups demonstrated, however, that 
upon growth factor activation, two RTKs, 
EGFR and PDGFR, move from the plasma 
membrane and pass by the ER. A high 
percentage of these internalized RTKs interacted with PTP1B. 
The authors used FRET to visualize this interaction in cells by 
engineering a PTP1B mutant that traps its RTK substrate.
D
EGFR and 
PTP1B interact 
at the ER 
(green).
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The distinct locations of kinase activation by phosphorylation (at 
the plasma membrane) and dephosphorylation by PTP1B (at the ER) 
may provide a necessary time delay between turning on and off 
signaling receptors, thus regulating the lifespan of an active RTK 
signal. Dephosphorylation could deactivate receptors before they are 
either sent back to the plasma membrane or to degradative lysosomes.
Reference:
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has sequence similarity to c-Cbl, an E3 ligase that ubiquitinates 
phosphorylated tyrosine kinase receptors and prompts their 
internalization and degradation. Hakai, which is Japanese for 
destruction, increases ubiquitination of the E-cadherin complex, 
particularly when E-cadherin is phosphorylated by Src or in 
response to growth factors.
 Disruption of cell 
adhesion by Hakai 
causes cell scattering, 
similar to that 
observed during the 
transition to a 
mesenchymal pheno-
type. Birchmeier 
now plans to test 
whether Hakai’s 
motility-promoting 
properties are used by tumor cells to trigger invasion and 
metastasis.
 
Reference:  Fujita, Y., et al., 2002. 
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Overexpression of Hakai (right) increases 
endocytosis and degradation 
of E-cadherin (white).
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